BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30837324)

  • 1. Bioinformatics analysis of prognostic value of
    Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
    Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
    Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
    Wang Q; Zhao S; Gan L; Zhuang Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
    Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
    Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
    Jing X; Liang H; Hao C; Yang X; Cui X
    Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of potential prognostic biomarkers among Krüppel-like transcription Factors (KLFs) in breast cancer.
    Cheng L; Shi L; Dai H
    Cancer Biomark; 2019; 26(4):411-420. PubMed ID: 31640084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
    Chen WQ; Yang SJ; Xu WX; Deng F; Wang DD; Tang JH
    Medicine (Baltimore); 2021 Oct; 100(42):e27489. PubMed ID: 34678879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
    Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
    BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
    Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
    Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis of potential therapeutic targets among
    Chen WX; Lou M; Cheng L; Qian Q; Xu LY; Sun L; Zhu YL; Dai H
    Oncol Lett; 2019 Dec; 18(6):6017-6025. PubMed ID: 31788076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
    Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
    Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.